Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease

Abstract

A positive association between serum adalimumab concentration and remission was identified at several time points. A threshold concentration reliably associated with remission was not identified. Further prospective evaluations are needed before recommendations for adalimumab concentration monitoring can be made.